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he dark story of the yellow ﬁve  meters  in  height.  The  patient  had  no  concomitant  dis-
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tose: A case report of
epatoxicity associated with
ochlospermum vitifolium
onsumption as herbal remedy
a historia oscura de la rosa amarilla: un
eporte de caso de toxicidad hepática
sociado al  consumo de Cochlospermum
itifolium  como remedio herbolario
Drug-induced  liver  injury  (DILI)  is  one  of  the  most  chal-
enging  disorders  faced  by  the  gastroenterologist.1 The
stimated  annual  incidence  rate  of  DILI  is  13.9-24  per
00,000  inhabitants.2 It  is  still  a  diagnosis  of  exclusion  based
rimarily  on  a  detailed  history  and  the  judicious  use  of  blood
ests,  hepatobiliary  imaging,  and  liver  biopsy.1,3
Herbal  and  dietary  supplements  (HDSs)  are  currently
onsumed  on  a  large  scale  in  Mexico,  due  to  the  com-
on  misperception  that  they  are  innocuous  because  they
re  ‘‘natural’’.  However,  HDS  hepatotoxicity  has  received
ncreasing  attention  over  the  past  few  years,  in  part  because
DSs  have  been  recognized  in  the  United  States  as  being
he  second  most  common  cause  of  DILI  cases.1 The  Adverse
vent  Reporting  Program  of  the  Food  and  Drug  Administra-
ion  is  responsible  for  the  increased  awareness  of  safety
oncerns  and  encourages  individuals  and  healthcare  profes-
ionals  to  report  adverse  effects.4 We  present  herein  the
ase  of  a  25-year-old  woman  diagnosed  with  acute  herbal-
nduced  hepatotoxicity  secondary  to  the  consumption,  in  the
orm  of  an  infusion,  of  Cochlospermum  vitifolium  (C.  viti-
olium).  Commonly  known  as  ‘‘yellow  rose,’’  ‘‘panicua’’,
r  ‘‘pongolote’’,  it  is  used  as  an  herbal  remedy  for  the
‘treatment’’  of  jaundice  and  metabolic  syndrome.5,6
Wild  C.  vitifolium  belongs  to  the  Cochlospermaceae  fam-
ly  and  is  a  shrub  with  yellow  ﬂowers  that  grows  up  to
 Please cite this article as: Martínez-Rodriguez L, Murguía-
ernández K, García-Juárez I, Uribe-Esquivel M, Gómez-Reyes E.
a historia oscura de la rosa amarilla: un reporte de caso de toxi-
idad hepática asociado al consumo de Cochlospermum vitifolium
omo remedio herbolario. Revista de Gastroenterología de México.
015;80:220--222.
i
s
s
c
255-534X/© 2014 Asociación Mexicana de Gastroenterología. Published
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nases  when  she  was  admitted  to  the  Instituto  Nacional
e  Ciencias  Médicas  y  Nutrición  (a  tertiary  care  hospital)
ith  a 7-day  history  of  jaundice.  During  the  initial  medi-
al  assessment,  blood  pressure  and  heart  and  respiratory
ates  were  within  normal  values  and  her  temperature  was
6.7 ◦C.  Physical  examination  showed  she  was  icteric,  with
onjunctival  icterus  and  weakness,  and  her  body  mass  index
as  24.5  kg/m2. She  did  not  complain  of  fever,  changes  in
evel  of  consciousness,  vomiting,  abdominal  pain,  seizures,
r  gastrointestinal  bleeding.  The  serum  liver  function  tests
ere  altered,  reporting  serum  ALT  and  AST  >  3  x  the  upper
imit  of  normal  (ULN),  serum  total  bilirubin  elevated  to  >  2
 the  ULN  and  the  calculated  R-value  (ALT/ULN  divided  by
P/ULN),  suggesting  a  cholestatic  injury  pattern.1
Serologic  testing  for  hepatitis  A,  B,  C  and  E  viruses,
nd  serologic  tests  for  antinuclear  antibodies,  anti-
itochondrial  antibodies,  and  anti-smooth-muscle  antibod-
es  were  all  negative  (table  1).  Hepatobiliary  ultrasound
eported  hepatosplenomegaly  and  severe  steatosis.  In  the
epatic  biopsy  the  pathologist  reported  steatohepatitis  with
evere  activity  and  mild  ﬁbrosis  (Brunt-Kleiner  3)  with  mixed
acro  and  microvesicular  steatosis,  and  marked  aggre-
ates  of  inﬂammatory  cells  predominantly  in  the  perivenular
paces  with  subtle  necrosis.  Moderate  hepatocyte  ballooning
nd  satellitosis  were  found,  characterized  by  the  presence
f  neutrophils  and  eosinophils.  The  patient  revealed  that
he  had  been  taking  a ‘‘panicua’’  infusion  as  a  recommen-
ation  from  a  relative  ‘‘just  to  stay  healthy’’,  drinking  up
o  1-2  cups  daily  for  3-4  months  before  medical  examination
ﬁg.  1).
The  patient  was  told  to  suspend  the  ‘‘panicua’’  infusion
mmediately.  She  had  a medical  follow-up  once  a  month
or  the  next  6  months  at  the  steatohepatitis  clinic  in  our
ospital.  During  the  ﬁrst  4  weeks  of  surveillance  there  was
 clinically  signiﬁcant  decrease  in  hepatic  enzymes  and
fter  the  6-month  wash-out  period  the  hepatic  enzymes
nd  bilirubin  returned  to  normal  values  (table  1).7 A
iver  biopsy  was  not  performed  at  the  end  of  the  follow-
p,  because  the  patient  did  not  give  her  consent  for
he  procedure.  A  key  question  in  herbal  hepatotoxicity
s  the  appropriate  attribution  of  causality  method  for
uspected  cases.  Data  acquisition,  documentation,  and  pre-
entation  of  these  kinds  of  problems  are  a  diagnostic
hallenge.
 by Masson Doyma México S.A. This is an open access article under
d/4.0/).
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Figure  1  A.  Hepatosplenomegaly  and  severe  steatosis  (grade  3)  without  dilated  biliary  ducts.  B.  Steatohepatitis  with  severe
activity and  mild  ﬁbrosis  (Brunt-Kleiner  3).  C.  Photomicrography  showing  satellitosis  (adipocyte  surrounded  by  neutrophils  and
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Some  appropriate  causality  assessment  methods  for
suspected  herbal  hepatotoxicity  are  the  Council  for  Interna-
tional  Organizations  of  Medical  Sciences  (CIOMS)  scale  and
the  Roussel  Uclaf  Causality  Assessment  Method  (RUCAM).1
Both  scales  are  structured,  quantitative,  liver-speciﬁc,  and
validated  for  hepatotoxicity.  They  are  intended  for  bedside
use  in  a  clinic  and  yield  a  summed  score  indicating  the  like-
lihood  of  DILI.1,8
Points  are  given  or  taken  away  based  on  the  timing
of  exposure,  liver  biochemistry  dechallenge,  risk  factors
for  DILI,  competing  medications,  competing  diagnoses,  and
rechallenge  information.1 In  the  present  case,  both  the
RUCAM  and  CIOMS  scales  showed  a  ‘‘probable’’  DILI  due  to
C.  vitifolium  consumption  as  the  primary  candidate  (+6
points  and  +9  points,  respectively).1,8 In  the  case  of  HDS
hepatotoxicity,  important  limitations  to  the  causality  assess-
ment  process  must  be  considered:None  of  the  causality  assessment  processes  currently
used  were  created  speciﬁcally  for  HDSs,  dietary  sup-
plements  are  susceptible  to  ingredient  or  concentration
variability  over  time,  they  are  usually  unlabeled,  and  in
p
s
‘he  speciﬁc  case  of  herbal  remedies,  they  could  be  con-
aminated  with  heavy  metals  or  microbes.  Although  there
s  much  information  at  the  folk-knowledge  level,  there  are
ardly  any  health  regulations  regarding  their  collection,  cul-
ivation,  local  production,  and  processing.1,9
This  case  highlights  the  importance  of  encouraging
atients  to  report  the  use  of  HDSs  to  their  health-care
roviders.  The  same  diagnostic  approach  for  DILI  is  appli-
able  to  HDS  hepatotoxicity  suspicion  and  the  exclusion  of
ther  causes  and  diagnosis  can  be  made  with  conﬁdence  in
he  setting  of  recent  HDS  use.1,10 Patients  with  suspected
DS  hepatotoxicity  should  suspend  all  HDSs  and  be  moni-
ored  for  resolution  of  their  liver  injury.  This  case  is  the  ﬁrst
eport  of  C.  vitifolium  (‘‘panicua’’)  as  a  potential  hepato-
oxic  plant.  Experiments  in  rats  showed  that  C.  vitifolium
xtract  plays  an  important  role  in  hypertension  regulation
hrough  nitric  oxide  synthesis  and  possibly  prostaglandin  I2
roduction  and  potassium  channel  activation  under  exces-
ive  endothelial  dysfunction  conditions.6,7
More  studies  on  the  potential  toxic  metabolites  from
‘panicua’’  are  needed.
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Table  1  Biochemical  parameters  during  patient  progression:  initial  values  and  at  6  months  after  suspending  ‘‘panicua’’
consumption).
Biochemical  parameters  Normal  values  Initiala Six  months  latera
Hemoglobin  (g/dL)  13-17  10.8  13
Leukocytes  (L)  4,500-11,400  7,400  6,400
Platelets (U)  150,000-350,000  185,000  257,000
Total bilirubin  (mg/dL) 0.2-1  7.86  0.88
Direct bilirubin  (mg/dl) 0.1-0.3  3.28  0.18
International  normalized  ratio 0.7-1.3  1.1  1.0
Alkaline phosphatase  (U/L)  27-88  1201  20
ALT (U/L)  7-52  221  17
AST (U/L)  13-39  432  20
GGT (U/L)  9-64  1175  63
Fasting glucose  (mg/dl)  <100  80  88
HbA1c (%)  3-6  4.5  4.6
Triglycerides  (mg/dl)  <150  120  111
Total cholesterol  (mg/dl)  <200  158  149
ANA 1:80  1:80
ASMA Negative  Negative  Negative
AMA Negative  Negative  Negative
VHA Negative  Negative  Negative
HBV Negative  Negative  Negative
HCV Negative  Negative  Negative
HEV Negative  Negative  Negative
AMA: anti-mitochondrial antibody; ANA: antinuclear antibody; ASMA: Anti-smooth muscle antibody; HBV: hepatitis B virus; HCV: hepatitis
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◦C virus; HEV: hepatitis E virus.
a Lab reference value.
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